Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Cancer

October 24, 2017 6:59 PM UTC

Patient sample, cell culture and mouse studies suggest a mAb against IL-12B monomer could help treat prostate cancer. In patient serum samples, levels of IL-12B monomer were higher than in serum sampl...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Rush University Medical Center

BCIQ Target Profiles

Interleukin-12B (IL-12B)